| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5587446 | Diabetes Research and Clinical Practice | 2017 | 23 Pages |
Abstract
Besides its effects similar to those of insulin and metformin in glycemic control and in reducing need for insulin, 6-month sitagliptin therapy may also associated with improvement of cognitive function in elderly diabetic patients with and without AD. Further randomized controlled trials are needed to support these results.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Endocrinology
Authors
Ahmet Turan Isik, Pinar Soysal, Adnan Yay, Cansu Usarel,